LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

AI-Based Breathalyzer Can Electronically `Smell` Coronavirus and Detect Infection in Under Two Minutes

By LabMedica International staff writers
Posted on 07 Jan 2021
Print article
Image: GeNose C19 (Photo courtesy of Gadjah Mada University)
Image: GeNose C19 (Photo courtesy of Gadjah Mada University)
A simple breathalyser test uses artificial intelligence (AI) to electronically "smell' the novel coronavirus and detect infection in less than two minutes.

Scientists at the Gadjah Mada University (Jogjakarta, Indonesia) have developed the GeNose C19 or Gadjah Mada Electronic Nose that rapidly detects COVID-19 using only a person’s breath. The electronic-based diagnostic tool uses the cloud computing system to deliver real-time diagnosis results and can also be run in parallel through a centralized diagnostic process to maintain data validity for all connected devices.

The device uses powerful filters and suction to remove all COVID-19 droplets or particles and sterilize itself for the next test. GeNose C19 offers the advantages of lower cost per test, instant test results, ease of mass production, and high specificity and sensitivity. The Indonesian government has granted a distribution permit for GeNose C19 which is already being used to screen patients for COVID-19 by three hospitals across the country.

"We need faster screening to prevent people getting infected," said Bambang Brodjonegoro, Indonesia's Minister for Research and Technology. "This will accelerate the detection process and mitigate the risk of the pandemic spreading."

Related Links:
Gadjah Mada University

Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.